✦ LIBER ✦

A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma

✍ Scribed by Katsutaro Shimaoka; David A. Schoenfeld; William D. Dewys; Richard H. Creech; Ronald Deconti

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 471 KB
Volume: 56
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19851101)56:9<2155::aid-cncr2820560903>3.0.co;2-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A prospective randomized trial of doxoru

A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer

✍ Massimo Lopez; Alma Contegiacomo; Patrizia Vici; Concetta Dello Ioio; Luigi Di L 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 2 views

Seventy-six patients with advanced breast cancer were entered into the current study. They were randomized to receive either idarubicin (IDA) 45 mg/m2 orally or doxorubicin (DX) 75 mg/m2 intravenously (IV), both drugs being administered every 3 weeks. Among 37 evaluable patients who received DX trea

A prospective, randomized phase III tria

A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma

✍ Cesar Blajman; L. Balbiani; J. Block; F. Coppola; R. Chacon; L. Fein; S. Bonicat 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

## Background: A prospective, multicenter, randomized, phase iii trial comparing the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide (fac) with a combination of vinorelbine and doxorubicin (na) in the treatment of patients with advanced breast carcinoma w

A phase II trial of neoadjuvant methotre

A phase II trial of neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of patients with locally advanced breast carcinoma

✍ Louise E. Morrell; Young J. Lee; Judith Hurley; Mayda Arias; Carolyn Mies; Steph 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Background: Traditionally, primary surgical therapy is considered unsuitable for the treatment of patients with locally advanced breast carcinoma (labc). multiple reports have documented the efficacy of primary chemotherapy in this group of patients. the purpose of this study was to investigate

Doxorubicin and CCNU with or without vin

Doxorubicin and CCNU with or without vincristine in patients with advanced refractory breast cancer a randomized trial

✍ Rowan T. Chlebowski; Reginald Pugh; John M. Weiner; Jerome B. Block; Joseph R. B 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 410 KB 👁 1 views

Randomized trial of carboplatin plus ami

Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumors

✍ G. Thomas Budd; Ram Ganapathi; David J. Adelstein; Robert Pelley; Thomas Olencki 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

## Background: To test the hypothesis that the cytoprotectant amifostine attenuates the thrombocytopenia produced by carboplatin, the authors performed a randomized trial comparing treatment with carboplatin alone versus the combination of amifostine and carboplatin. ## Methods: Patients with ref

A randomized Phase III trial of etoposid

A randomized Phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma

✍ Fikri İçli; İsmail Çelik; Faruk Aykan; Aytuǧ Üner; Ahmet Demirkazik; Ahmet Özet; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

## BACKGROUND. Gastric carcinoma is a substantial health problem in Turkey, and the majority of patients present with inoperable disease. The aim of this randomized trial was to assess the activity of 5-fluorouracil versus etoposide when combined with epirubicin plus cisplatin in patients with adv